Main Article Content
Recommendations for cervical cancer screening have had remarkable agreement from a number of medical societies, including the American College of Obstetricians and Gynecologists (ACOG), American Cancer Society (ACS), American Society of Cervical Colposcopy and Pathology (ASCCP), and the US Preventative Services Task Force (USPSTF). Reference to the recommended age for screening may need to be re-examined, in light of current data regarding the comparative age-related incidence of cervical malignancy, especially when recognizing the past utility of screening with exfoliative cytology in reducing subsequent mortality.
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
2. Cervical cancer screening and prevention. ACOG Practice Bulletin #168. October, 2016.
3. Fontham ETH, Wolf AMD, Church TR, Etzioni R, et al: Cervical cancer screening for individuals of average risk: CA Cancer J Clinic 2020;70:321-346.
4. Beachler DC, Tota JE, Silver MI, Kreimer AR, Hildesheim A, Wentzensen N, Schiffman M, Shiels MS: Trends in cervical cancer incidence in younger US women from 2000-2013. Gynecol Oncol 2017;144(2): 391-395.
5. Morris CP, Chowsilpa S, Mustafa S, Chan I, Miller D, Matleki Z, Rodriguez EF: Impact of the current US Preventive Services Task Force recommendations for cervical cancer screening in young women 21-29 years old. Am J Clin Pathol 2020;153:734-742.
6. Korkidakis A, Bryson P, Jamieson MA: Outcomes of a decade of routine cervical screening in a Canadian adolescent obstetrics clinic. J Obstet Gynaecol Can 2016; 38(1):51-5.
7. Maura G, Chaignot C, Weill A, Alla F, Heard I: Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study. Eur J Cancer Prevention 2018;27:479-485.
8. Xie S, Pan S, Zou S, Zhu H, Zhu X. Characteristics and treatments of patients aged 65 years or over with cervical cancer. Clin Interv Aging 2020;15:841-851.
9. Pollack LM, Ekwueme DU, Hung MC, Miller JW, Chang SH. Estimating the impact of increasing cervical cancer screening in the National Breast and Cervical Cancer Early Detection Program among low-income women in the USA. Cancer Causes Control 2020;31:691-702.
10. Balaji R, MacCosham A, Williams K, El-Zein M, Franco EL. Directionality of genital Human Papillomavirus infection transmission within heterosexual couples: a systematic review and meta-analysis. J Infect Dis 2020;222(11):19281-937.
11. Liu H, Umberson D, Xu M. Widowhood and mortality: gender, race/ethnicity, and the role of economic resources. Ann Epidemiol 2020;45:69-75.
12. Herbenick D, Reece M, Schick V, Sanders SA, Dodge B, Fortenberry JD. Sexual behavior in the United States: Results from a national probability sample of men and women ages 14-94. J Sex Med 2010;7(Suppl 5):255-265.
13. Tota JE, Isidean SD, Franco EL: Defining benchmarks for tolerable risk thresholds in cancer screening: impact of HPV vaccination on the future of cervical cancer screening. Int J Cancer 2020;147:3305-3312.
14. Canadian Task Force on Preventive Health Care. Recommendations on screening for cervical cancer. Can Med Assoc J 2013;185(1):35-45.
15. Rustagi AS, Kamineni A, Weiss NS: Point. Cervical cancer screening guidelines should consider observational data on screening efficacy in older women. Am J Epidemiol 2013;178(7):1020-1022.
16. Bus-Kwofie A, Chan C, Kahn R, Holcomb K: Clinical controversies in cervical cancer screening. Clin Obstet Gynecol 2019;62(4):644-655.